Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Psychedelic use appears to lead to lasting improvements in sexual functioning and satisfaction

by Eric W. Dolan
April 11, 2024
in Psychedelic Drugs
(Photo credit: OpenAI's DALL·E)

(Photo credit: OpenAI's DALL·E)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

In a recent study published in Scientific Reports, researchers have provided insight into the potential benefits of psychedelics like magic mushrooms and LSD in enhancing sexual function. Participants reported improvements in various aspects of their sexual well-being lasting several weeks post-experience, suggesting these drugs could offer more than just a mind-altering trip.

Psychedelics gained prominence in the mid-20th century for their potential in treating mood disorders and addiction. However, their association with the counterculture movements of the 1960s and subsequent regulatory crackdowns halted scientific research for decades. In recent years, the resurgence of interest in psychedelics has been bolstered by clinical trials suggesting their efficacy in mental health interventions, particularly for conditions like major depressive disorder (MDD).

Sexual dysfunction is a prevalent issue, especially among individuals with MDD, a leading cause of disability worldwide. Traditional antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), often exacerbate sexual dysfunction, leading to decreased treatment adherence and potential relapse of depressive episodes.

Given this backdrop, researchers at Imperial College London sought to fill a significant gap in the existing literature by quantitatively assessing the impact of psychedelics on sexual functioning and satisfaction.

To this end, the researchers recruited people who had either planned to consume psychedelics in a personal setting or were about to participate in an organized psychedelic ceremony. These settings spanned across a variety of classic psychedelics, including psilocybin (found in magic mushrooms), ayahuasca, DMT, San Pedro cactus, and LSD.

The participants completed questionnaires one week before their psychedelic experience (baseline), then four weeks and six months post-experience. A total of 261 adults were included in the analysis, mostly from the United States.

Participants reported significant improvements in their sexual experiences, including sexual pleasure, satisfaction with their own appearance, satisfaction and communication with their partner. These improvements were sustained over the weeks and months following the psychedelic experience, suggesting lasting benefits.

Notably, the perception of sex as a spiritual or sacred experience saw one of the most substantial upticks, echoing the anecdotal narratives about psychedelics fostering a deeper, more meaningful connection to one’s sexuality.

However, the reliance on self-reported data, the potential for bias in participant selection, and the observational nature of the findings were considerable limitations. The study’s observational nature precludes the establishment of causality and those who choose to opt into the study likely had a pre-existing positive view of psychedelics.

To overcome some of these limitations, the researchers also analyzed data from 59 people taking part in double-blind randomized controlled trial. The trial compared the outcomes of psilocybin therapy against those of escitalopram, a commonly prescribed selective serotonin reuptake inhibitor (SSRI).

The psilocybin therapy consisted of two dosing sessions where participants received an active dose of psilocybin under the close supervision of experienced therapists, coupled with a course of Acceptance and Commitment Therapy to enhance the therapeutic process. This was compared to the control group, which received escitalopram daily for six weeks and placebo doses on the supposed psilocybin dosing days.

By randomly assigning participants to either the psilocybin therapy group or the escitalopram group, and ensuring neither the participants nor the researchers knew who received which treatment until after the study concluded, the researchers minimized biases that could influence the outcomes.

Unlike the control group treated with escitalopram, which reported a general decrease in sexual satisfaction and increased instances of sexual dysfunction, the psilocybin group exhibited significant improvements. Participants in the psilocybin arm reported notable increases in sexual interest, arousal, activity, and overall satisfaction, with an absence of increased sexual anxiety, a common side effect associated with conventional antidepressants.

Tommaso Barba, first author of the study and PhD student based at the Centre for Psychedelic Research at Imperial College London, said: “We believe this is the first scientific study to explore the effects of psychedelics on sexual functioning.”

“Our findings suggest potential implications for conditions that negatively affect sexual health, including clinical depression and anxiety. This is particularly significant given that sexual dysfunction, often induced by antidepressants, frequently results in people stopping these medications and subsequently relapsing.”

“On the surface, this type of research may seem ‘quirky’, but the psychological aspects of sexual function – including how we think about our own bodies, our attraction to our partners, and our ability to connect to people intimately – are all important to psychological wellbeing in sexually active adults.

“Sexuality is a fundamental human drive. For example, we know that sexual dysfunction is linked to lower well-being in healthy adults, can impact relationship satisfaction, and is even linked to subjective happiness and ‘meaning in life’.”

Bruna Giribaldi, senior author on the paper and formerly based at the Centre for Psychedelic Research at Imperial, added: “So far, all the research on depression has only focused on whether treatments cause sexual dysfunction.”

“We wanted to make sure we went deeper than that and explored more aspects of sexuality that could be impacted by these treatments. We were interested in finding out whether psychedelics could influence people’s experiences of sexuality in a positive way, as it appeared from existing anecdotal evidence.”

“Sexual side effects are often underreported in clinical trials, as people tend to not directly report them unless explicitly asked. Aware of this, we were determined to thoroughly investigate this area.”

The researchers emphasized that although the results showing psilocybin’s effectiveness in treating depression are promising, it’s crucial to remember that these outcomes were achieved in highly controlled clinical settings. The psilocybin used in trials was precisely dosed and created in labs, accompanied by thorough psychological support from mental health professionals throughout the treatment process.

They also noted that there have been reports of sexually abusive behavior during psychedelic ceremonies and therapy, highlighting the need for heightened caution when powerful mind-altering substances are involved. “Relatedly, the use of psychedelic or empathogenic compounds in romantic contexts might also create complex relationship dynamics such as promoting feelings of attachment to an ordinarily undesired or abusive partner, sexual activities done under drug influence that are later regretted, or wrongly perceiving another individual as romantically or sexually interested or engaged—an issue that extends to other psychoactive drugs such as alcohol.”

Looking forward, the study’s authors advocate for more inclusive research exploring the effects of psychedelics on sexual functioning across diverse populations. They also highlight the need for studies that incorporate partners’ perspectives. Investigating the impact of psychedelic use on sexual relationships from a dyadic perspective (considering both partners) could offer insights into how these substances affect intimacy, communication, and satisfaction within relationships.

David Erritzoe, the clinical director of the Centre for Psychedelic Research, concluded: “This study shines yet more light on the far-reaching effects of psychedelics on an array of psychological functioning.”

“While the findings are indeed interesting, we are still far from a clear clinical application, because psychedelics are yet to be integrated into the medical system. In future, we may be able to see a clinical application, but more research is needed.”

The study, “Psychedelics and sexual functioning: a mixed-methods study,” was authored by Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M. Peill, Leor Roseman, David J. Nutt, David Erritzoe, Robin Carhart-Harris, and Bruna Giribaldi.

TweetSendScanShareSendPin1ShareShareShareShareShare

RELATED

Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails
Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

People with depression face significantly greater social and health-related challenges

Stress disrupts gut and brain barriers by reducing key microbial metabolites, study finds

New research reveals hidden biases in AI’s moral advice

7 subtle signs you are being love bombed—and how to slow things down before you get hurt

A simple breathing exercise enhances emotional control, new research suggests

Despite political tensions, belief in an impending U.S. civil war remains low

Girls are better than boys at detecting their own ADHD symptoms

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy